Seven ventures presented at this year's PVCC finale
IE CambridgeThe team behind the new venture, CardiOn, have created a therapeutic that can stimulate the proliferation of adult heart cells, a breakthrough previously considered impossible. Presented by Dr Jin Seok Lee, it won the competition’s first prize, a £20,000 investment awarded by Cambridge Enterprise Ventures.
The second prize, awarded by Cambridge Innovation Capital, and the audience prize both went to Haptos Technology, presented by Dr Zhuo Chen from the Department of Engineering at the University of Cambridge.
The Postdoc Venture Creation Challenge (PVCC) is designed to help University of Cambridge postdocs take their first steps in transforming research into real-world ventures. Over several months, the participating teams learn what it takes to build a company, develop their ideas and refine their value propositions. The journey culminates in the Grand Finale, where the finalists pitch their ventures to a panel of judges and an audience.
This year, the event took place at Jesus College, with seven teams taking to the stage in front of a packed audience of more than 150 people. There was a palpable sense of excitement in the room, with an enthusiastic crowd cheering on the teams as they presented their ideas. At the end of the night, CardiOn and Haptos were crowned winners of a competition whose alumni have already raised over £200 million.
Dr Jin Seok Lee, Postdoctoral Researcher at the University of Cambridge and winner of this year’s PVCC said:
“The team worked really hard to get here. We didn’t expect to win, but it’s a huge leap forward for us in making this a reality for patients. The PVCC is wonderful, we’ve been through many steps to get here, and the mentors, trainers and organisers have been incredibly insightful in guiding us in this journey.”
With validated in vivo proof-of-concept, CardiOn’s approach provides a scalable, non-surgical solution to re-muscularise failing hearts and restore functional capacity to millions of patients. Its mRNA-based regenerative therapy stimulates significant proliferation of adult heart cells – a remarkable breakthrough which was not considered possible until now. The innovation stems from the Department of Pharmacology and The Gurdon Institute and the venture is co-founded by Dr Jin Seok Lee and Dr Catherine Wilson.
Second place went to Haptos Technology, pitched by Dr Zhuo Chen, who was awarded the £10,000 prize by Cambridge Innovation Capital. Chen was also awarded the audience prize. Helping improve robotic dexterity and safety in manufacturing, agriculture and healthcare, Haptos is developing a flexible electronic skin that gives robots a sensitive sense of touch. This innovation comes from the Department of Engineering, with the venture co-founded by Dr Zhuo Chen, Professor Tawfique Hasan, Dr Doga Doganay, Madhurjot Sohi and Amir Nateghi.
Christine Martin, one of the judges and Head of Ventures at Cambridge Enterprise, said:
“This is a wonderful event. The PVCC gives us the opportunity to look into our own future. These are companies we hope to be able to work with for the next couple of years and it’s a great opportunity to see them work through these first steps and start building meaningful relationships with them all.”
Richard Hall, Associate at Cambridge Innovation Capital and one of the judges, said:
“The seven pitches were all excellent. It’s been brilliant watching them all for the past few months as they’ve gained confidence and a broader market understanding. CardiOn, the winner, has truly demonstrated a clarity of vision for the journey ahead, for what can be a complex roadmap. The second winner, Haptos, has the potential to unlock many applications in the field of robotics, so it’ll be very interesting to see where this technology goes on from here.”
The Postdoc Venture Creation Challenge (PVCC) welcomes innovative ideas across DeepTech, life sciences, AI, software, and social impact. It has a track record of producing some of Cambridge’s most exciting startups. Previous winners have gone on to raise over £200m in investment, with alumni including Xampla, Nu Quantum and 52 North.
The PVCC is more than just a competition. Taking place over six months, applicants benefit from hands-on training, mentoring and talks from other academics turned founders. It is delivered by IE Cambridge in partnership with ideaSpace and the Postdoc Academy and sponsored by Cambridge Enterprise, Mishcon de Reya, PEM, Cambridge Innovation Capital (CIC) and HSBC Innovation Banking.